HCA Healthcare Inc banner

HCA Healthcare Inc
NYSE:HCA

Watchlist Manager
HCA Healthcare Inc Logo
HCA Healthcare Inc
NYSE:HCA
Watchlist
Price: 471.34 USD 0.03% Market Closed
Market Cap: $105.4B

EV/EBIT

12.2
Current
2%
More Expensive
vs 3-y average of 11.9

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
12.2
=
Enterprise Value
$160.6B
/
EBIT
$12B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
12.2
=
Enterprise Value
$160.6B
/
EBIT
$12B

Valuation Scenarios

HCA Healthcare Inc is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (11.9), the stock would be worth $461.49 (2% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-6%
Maximum Upside
+61%
Average Upside
28%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 12.2 $471.34
0%
3-Year Average 11.9 $461.49
-2%
5-Year Average 11.5 $443.41
-6%
Industry Average 19.2 $743.81
+58%
Country Average 19.6 $758.23
+61%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
$160.6B
/
Jan 2026
$12B
=
12.2
Current
$160.6B
/
Dec 2026
$12.5B
=
12.9
Forward
$160.6B
/
Dec 2027
$13B
=
12.3
Forward
$160.6B
/
Dec 2028
$13.7B
=
11.7
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

Lower than 76% of companies in the United States of America
Percentile
24th
Based on 8 638 companies
24th percentile
12.2
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

HCA Healthcare Inc
Glance View

HCA Healthcare Inc., a titan in the American healthcare landscape, traces its origins back to 1968 when Dr. Thomas F. Frist Sr., his son Dr. Thomas F. Frist Jr., and businessman Jack C. Massey founded the company with a vision to provide quality care in hospital settings. Fast forward to today, HCA operates an extensive network of 182 hospitals and over 2,300 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics, spreading its healthcare prowess across 20 U.S. states and the United Kingdom. At the core of its operations is a robust infrastructure dedicated to delivering comprehensive medical services ranging from basic emergency care to intricate surgical procedures and specialized treatments. This strategic breadth allows HCA to harness economies of scale, enhancing operational efficiency and improving patient outcomes. The financial engine fueling HCA Healthcare is multifaceted, driven primarily by patient services revenues. This encompasses everything from inpatient care, outpatient services, and ancillary services like laboratories and imaging. Such diverse offerings not only boost the company's revenue streams but also position it to adapt to evolving healthcare needs and regulatory changes. By continuously investing in state-of-the-art medical technology and adopting innovative care models, HCA enhances its service quality and patient retention, which results in stabilized financial performance. With a focus on both urban and suburban communities, HCA leverages its clinical expertise and geographic reach to capture significant market share, fostering a sustainable and profitable business model that underscores its stature as a leader in the healthcare sector.

HCA Intrinsic Value
561.05 USD
Undervaluation 16%
Intrinsic Value
Price $471.34
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett